Ngā hua rapu - Torrisi, Jean

Waxing and Waning Pattern of mTOR Inhibitor-Associated Pneumonitis in Renal Cell Carcinoma Patients: A Retrospective Observational Study mā Gluskin, Jill, Plodkowski, Andrew, Girshman, Jeffrey, Sarasohn, Debra, Viteri-Jusué, Ainhoa, Hayan, Sumar, Torrisi, Jean

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A Multimodality Triage Algorithm to Improve Cytoreductive Outcomes in Patients Undergoing Primary Debulking Surgery for Advanced Ovarian Cancer: A Memorial Sloan Kettering Cancer C... mā Straubhar, Alli M., Filippova, Olga T., Cowan, Renee A., Lakhman, Yulia, Sarasohn, Debra M., Nikolovski, Ines, Torrisi, Jean M., Ma, Weining, Abu-Rustum, Nadeem R., Gardner, Ginger J., Sonoda, Yukio, Zivanovic, Oliver, Chi, Dennis S., Roche, Kara Long

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Phase II Study of LY3023414 in Patients with Advanced Endometrial Cancer Harboring Activating Mutations in the PI3K Pathway mā Rubinstein, Maria M., Hyman, David M., Caird, Imogen, Won, Helen, Soldan, Krysten, Seier, Kenneth, Iasonos, Alexia, Tew, William P., O’Cearbhaill, Roisin E., Grisham, Rachel N., Hensley, Martee L., Troso-Sandoval, Tiffany, Sabbatini, Paul, Guillen, Joyce, Selcuklu, S. Duygu, Zimel, Catherine, Torrisi, Jean, Aghajanian, Carol, Makker, Vicky

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial mā Zamarin, Dmitriy, Walderich, Sven, Holland, Aliya, Zhou, Qin, Iasonos, Alexia E, Torrisi, Jean M, Merghoub, Taha, Chesebrough, Lewis F, Mcdonnell, Autumn S, Gallagher, Jacqueline M, Li, Yanyun, Hollmann, Travis J, Grisham, Rachel N, Erskine, Courtney L, Block, Mathew S, Knutson, Keith L, O’Cearbhaill, Roisin E, Aghajanian, Carol, Konner, Jason A

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Vemurafenib for BRAF V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study mā Diamond, Eli L., Subbiah, Vivek, Lockhart, A. Craig, Blay, Jean-Yves, Puzanov, Igor, Chau, Ian, Raje, Noopur S., Wolf, Jurgen, Erinjeri, Joseph P., Torrisi, Jean, Lacouture, Mario, Elez, Elena, Martínez-Valle, Ferran, Durham, Benjamin, Arcila, Maria E., Ulaner, Gary, Abdel-Wahab, Omar, Pitcher, Bethany, Makrutzki, Martina, Riehl, Todd, Baselga, José, Hyman, David M.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

AKT Inhibition in Solid Tumors With AKT1 Mutations mā Hyman, David M., Smyth, Lillian M., Donoghue, Mark T.A., Westin, Shannon N., Bedard, Philippe L., Dean, Emma J., Bando, Hideaki, El-Khoueiry, Anthony B., Pérez-Fidalgo, José A., Mita, Alain, Schellens, Jan H.M., Chang, Matthew T., Reichel, Jonathan B., Bouvier, Nancy, Selcuklu, S. Duygu, Soumerai, Tara E., Torrisi, Jean, Erinjeri, Joseph P., Ambrose, Helen, Barrett, J. Carl, Dougherty, Brian, Foxley, Andrew, Lindemann, Justin P.O., McEwen, Robert, Pass, Martin, Schiavon, Gaia, Berger, Michael F., Chandarlapaty, Sarat, Solit, David B., Banerji, Udai, Baselga, José, Taylor, Barry S.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa